Your search returned 5 results.

Results
	1.	Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions. [electronic resource] by Namour, Florence Desrivot, Julie Van der Aa, Annegret Harrison, Pille Tasset, Chantal van't Klooster, Gerben Producer: 20161213 In: Drug metabolism letters vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects. [electronic resource] by Namour, Florence Galien, René Van Kaem, Tim Van der Aa, Annegret Vanhoutte, Frédéric Beetens, Johan Van't Klooster, Gerben Producer: 20171120 In: British journal of clinical pharmacology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection. [electronic resource] by Namour, Florence Diderichsen, Paul Matthias Cox, Eugène Vayssière, Béatrice Van der Aa, Annegret Tasset, Chantal Van't Klooster, Gerben Producer: 20160420 In: Clinical pharmacokinetics vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen. [electronic resource] by Sankatsing, Sanjay U C Weverling, Gerrit J Peeters, Monika van't Klooster, Gerben Gruzdev, Boris Rakhmanova, Aza Danner, Sven A Jurriaans, Suzanne Prins, Jan M Lange, Joep M A Producer: 20040607 In: AIDS (London, England) vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Correlations between factors determining the pharmacokinetics and antiviral activity of HIV-1 non-nucleoside reverse transcriptase inhibitors of the diaryltriazine and diarylpyrimidine classes of compounds. [electronic resource] by Lewi, Paul Arnold, Eddy Andries, Koen Bohets, Hilde Borghys, Herman Clark, Arthur Daeyaert, Frits Das, Kalyan de Béthune, Marie-Pierre de Jonge, Marc Heeres, Jan Koymans, Luc Leempoels, Jos Peeters, Jef Timmerman, Philip Van den Broeck, Walter Vanhoutte, Frédéric Van't Klooster, Gerben Vinkers, Maarten Volovik, Yulia Janssen, Paul A J Producer: 20090924 In: Drugs in R&D vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)